Ubs Group Ag Maia Biotechnology, Inc. Transaction History

Ubs Group Ag

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.54 - $3.87 $42,379 - $64,570	16,685 New	16,685 $46,000
Q4 2023 Feb 09, 2024	BUY	$0.83 - $2.54 $717 - $2,197	865 Added 650.38%	998 $1,000
Q3 2023 Nov 09, 2023	BUY	$1.42 - $2.41 $188 - $320	133 New	133 $0
Q1 2023 May 12, 2023	BUY	$3.06 - $4.84 $2,812 - $4,447	919 Added 30.33%	3,949 $13,000
Q4 2022 Feb 08, 2023	SELL	$3.1 - $3.85 $4,829 - $5,998	-1,558 Reduced 33.96%	3,030 $10,000
Q3 2022 Nov 10, 2022	BUY	$3.25 - $7.8 $14,911 - $35,786	4,588 New	4,588 $15,000

1.34M

Ticker MAIA
Exchange
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,935,900
Market Cap $20.6M
Description
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.